Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Cardiotoxicity × Proton Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 6 Brain Neoplasms 6 Sarcoma 4 Carcinoma, Hepatocellular 4 Solid Tumor, Adult 3 Carcinoma, Non-Small-Cell Lung 3 Pituitary Neoplasms 2 Meningioma 2 Liver Neoplasms 2 Glioma 2 Esophageal Neoplasms 2 Breast Neoplasms 2 Thymus Neoplasms 1 Thymoma 1 Thoracic Neoplasms 1 Solid Tumor 1 Rhabdomyosarcoma 1 Recurrence 1 Radiation Injuries 1 Prostate Adenocarcinoma 1 Pediatric Cancer Patients 1 Parotid Neoplasms 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Malignant Brain Glioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1

Interventions

Exercise 6 salicylhydroxamic acid 2 High-Intensity Interval Training 2 Echocardiography 2 sacubitril and valsartan sodium hydrate drug combination 1 mitoquinone 1 epicatechin gallate 1 candesartan 1 Therapeutics 1 Secondary Prevention 1 Restraint, Physical 1 Rehabilitation 1 Proton Therapy 1 Proteins 1 Palliative Care 1 Methods 1 Medical History Taking 1 Magnetic Resonance Spectroscopy 1 Laser-Doppler Flowmetry 1 Ivabradine 1 Heart Rate 1 Heart Function Tests 1 Exercise Test 1 Electrocardiography 1 Echocardiography, Stress 1 Blood Pressure 1 Blood Cell Count 1 Biomarkers 1 Anthropometry 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04822077 2021-03-30

PROTHYM

Swedish Lung Cancer Study Group

Phase NA Recruiting

Thymoma, Thymus Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡